(Q45932691)

English

Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 study.

scientific article published on 12 December 2014

In more languages
default for all languages
No label defined

No description defined

Statements

Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 study. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit